Introduction/Background To determine the probability of increase in recurrence risk of Fertility-Sparing Surgery (FSS) in Borderline Ovarian Tumors (BOT).
Methodology Our retrospective study looks back between November 2015- February 2023. We evaluated 52 patients, diagnosed with BOT and had their first surgery, demographic features, treatments and follow-up datas. The prior objective was to determine the recurrence risk of FSS in patients diagnosed with BOT.
Results Median age of the patients included in the study is 40 (min: 19-max: 78). 71.2% of the patients were in reproductive ages and 18 patients(34.6%) were nulliparous women. The median values were found as CA 125: 58.8(min:9-max:5668), CA 19–9: 12.3(min:0-max: 6821).
Total hysterectomy with bilateral salpingo-oophorectomy procedure was performed to the 48.1% of the patients. 24 out of 37 patients in reproductive ages were treated with FSS. According to follow-up datas, in 11.4% of 44 cases(5/44) recurrence occurred. Median follow-up duration is 46 months(min:2-max: 96). While recurrence rate was 17.4% in FSS performed cases, it was 4,8% in other group. Even though there was a threefold increase in recurrence rate in FSS performed cases, it’s not statistically significant due to small number of cases. Log Rank test was used in analysis of disease-free survival time and no significant difference was seen(p=0,134).
Conclusion In Fertility-Sparing Surgery recurrence rate of BOT is three times higher than classical approach.
Disclosures The authors have no conflict of interest related this research
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.